VEGF-A drugs for Age-Related Macular Degeneration
27 tracked VEGF-A drugs in the Age-Related Macular Degeneration race. The class explanation lives on the VEGF-A page; the full indication pipeline across every mechanism is on the Age-Related Macular Degeneration page.
13 approved / phase 46 Phase 31 Phase 2/31 Phase 16 preclinical / unstaged
Head-to-head evidence: Aflibercept vs Aflibercept (Afiveg) · Aflibercept vs Aflibercept (Eyluxvi) · Aflibercept vs Aflibercept (Mynzepli) · Aflibercept vs Aflibercept (Vgenfli) · Aflibercept vs BAT5906 · Aflibercept vs Brolucizumab-Dbll